Latest Regulatory Approvals News

Diatreme Resources reported progress on its Northern Silica Project with key regulatory approvals and metallurgical successes, while agreeing to sell its Clermont Copper/Gold Project to Moonlight Resources, retaining a significant stake.

Anteris Technologies has enrolled the first patients in its pivotal PARADIGM Trial, testing the DurAVR Transcatheter Heart Valve against leading competitors in a global study.

Bathurst Resources reported a Q1 FY26 EBITDA of NZD 5.2 million, maintaining full-year guidance and progressing major development projects in New Zealand and Canada.

Bass Oil reported steady quarterly oil production with a 20% increase in Indonesian output following a production enhancement program. The company is poised to enter the East Coast Gas Market pending regulatory approval for the Vanessa gas field acquisition.

Element 25 Limited has raised AU$10 million to advance its Butcherbird Expansion Project in Western Australia, aiming to increase manganese production and support its innovative battery materials refinery in the US.

Alliance Nickel has appointed financial advisors to explore a SPAC transaction for a Nasdaq listing, aiming to tap into premium US capital markets for its NiWest Nickel-Cobalt Project. The move follows a robust feasibility study and a strategic partnership with automaker Stellantis.

Toubani Resources has made significant strides in advancing its Kobada Gold Project, reporting promising drilling results and securing a substantial A$395 million funding package to support project development.

Wia Gold Limited has delivered a robust Scoping Study for its Kokoseb Gold Project in Namibia, confirming strong production potential and cost efficiency. The company also secured A$30 million to accelerate exploration and development activities.

Resouro Strategic Metals has engaged Independent Trading Group to provide market-making services on the TSX Venture Exchange, aiming to enhance liquidity and trading efficiency for its shares. This move comes as the company continues to advance its significant Brazilian mineral projects.

BetMakers Technology Group kicks off FY26 with a strong financial turnaround and strategic advances, including a promising acquisition and digital wagering expansion in Nevada.

BetMakers Technology Group has reported a remarkable 361% growth in adjusted EBITDA for Q1 FY26, driven by strong revenue gains and operational efficiencies, while advancing its strategic expansion into the Las Vegas racing market.

Memphasys has signed a pivotal supply agreement with Andro Diagnostics to distribute its Felix™ sperm separation system across over 200 IVF clinics in India, marking a major step in its new global go-direct commercial strategy.